{"id":806744,"date":"2022-07-12T19:16:33","date_gmt":"2022-07-12T17:16:33","guid":{"rendered":"https:\/\/15.161.165.86\/non-categorizzato\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/"},"modified":"2022-07-12T19:16:33","modified_gmt":"2022-07-12T17:16:33","slug":"knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/","title":{"rendered":"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding"},"content":{"rendered":"Areteia will initiate Phase 3 trials of lead candidate, dexpramipexole, a potential first-in-class oral drug for eosinophilic asthma, in late 2022\n\n\nInvestors led by Bain Capital Life Sciences to invest up to $350 million in Series A financing\n\n\nJorge Bartolome joins Areteia as CEO, bringing industry leadership experience in respiratory therapeutics\n\nPITTSBURGH, Pa. & SHORT HILLS, N.J.--(BUSINESS WIRE)--Areteia Therapeutics, Inc. (\u201cAreteia\u201d) today announces its launch as a clinical-stage biopharmaceutical company focused on putting asthma patients in better control of their disease \u2013 and back in control of their lives \u2013 with the first potential oral therapy for eosinophilic asthma. Areteia\u2019s lead drug candidate is dexpramipexo
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Areteia will initiate Phase 3 trials of lead candidate, dexpramipexole, a potential first-in-class oral drug for eosinophilic asthma, in late 2022 Investors led by Bain Capital Life Sciences to invest up to $350 million in Series A financing Jorge Bartolome joins Areteia as CEO, bringing industry leadership experience in respiratory therapeutics PITTSBURGH, Pa. & SHORT […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-806744","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nKnopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding - BeBeez\" \/>\n<meta property=\"og:description\" content=\"Areteia will initiate Phase 3 trials of lead candidate, dexpramipexole, a potential first-in-class oral drug for eosinophilic asthma, in late 2022 Investors led by Bain Capital Life Sciences to invest up to $350 million in Series A financing Jorge Bartolome joins Areteia as CEO, bringing industry leadership experience in respiratory therapeutics PITTSBURGH, Pa. & SHORT […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-12T17:16:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding\",\"datePublished\":\"2022-07-12T17:16:33+00:00\",\"dateModified\":\"2022-07-12T17:16:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\"},\"wordCount\":1379,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\",\"name\":\"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-07-12T17:16:33+00:00\",\"dateModified\":\"2022-07-12T17:16:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/","og_locale":"en_US","og_type":"article","og_title":"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding - BeBeez","og_description":"Areteia will initiate Phase 3 trials of lead candidate, dexpramipexole, a potential first-in-class oral drug for eosinophilic asthma, in late 2022 Investors led by Bain Capital Life Sciences to invest up to $350 million in Series A financing Jorge Bartolome joins Areteia as CEO, bringing industry leadership experience in respiratory therapeutics PITTSBURGH, Pa. & SHORT […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/","og_site_name":"BeBeez","article_published_time":"2022-07-12T17:16:33+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/"},"author":{"name":"","@id":""},"headline":"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding","datePublished":"2022-07-12T17:16:33+00:00","dateModified":"2022-07-12T17:16:33+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/"},"wordCount":1379,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/","name":"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-07-12T17:16:33+00:00","dateModified":"2022-07-12T17:16:33+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/806744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=806744"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/806744\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=806744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=806744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=806744"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=806744"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=806744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}